{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:03:46Z","timestamp":1779296626245,"version":"3.51.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T00:00:00Z","timestamp":1175212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T00:00:00Z","timestamp":1175212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00259-007-0407-4","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T18:59:51Z","timestamp":1175194791000},"page":"1324-1327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases"],"prefix":"10.1007","volume":"34","author":[{"given":"Jan","family":"Tennvall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boudewijn","family":"Brans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,30]]},"reference":[{"issue":"7","key":"407_CR1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.V89.7.2319","volume":"89","author":"Y Najean","year":"1997","unstructured":"Najean Y, Rain JD for the French Polycythemia Study Group. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65\u00a0years of age. Blood 1997;89(7):2319\u201327.","journal-title":"Blood"},{"issue":"1","key":"407_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0609.1995.tb01621.x","volume":"54","author":"L Brandt","year":"1995","unstructured":"Brandt L, Anderson H. Survival and risk of leukaemia in polycythemia vera and essential thrombocythemia treated with oral radiophosphorus. Eur J Haematol 1995;54(1):21\u20136.","journal-title":"Eur J Haematol"},{"issue":"2 suppl 3","key":"407_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.seminhematol.2004.02.007","volume":"41","author":"SM Fruchtman","year":"2004","unstructured":"Fruchtman SM. Treatment paradigms in the management of myeloproliferative disorders. Semin Hematol 2004;41 (2 suppl 3):18\u201322.","journal-title":"Semin Hematol"},{"issue":"2 Suppl 3","key":"407_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.02.006","volume":"41","author":"T Barbui","year":"2004","unstructured":"Barbui T. The leukaemia controversy in myeloprolifertive disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both? Semin Hematol 2004;41 (2 Suppl 3):15\u20137.","journal-title":"Semin Hematol"},{"key":"407_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.leukres.2004.10.002","volume":"29","author":"SM Fruchtman","year":"2005","unstructured":"Fruchtman SM, Petitt RM, Gilbert HS, Fiddler G, Lyne A. Anagrelide Study Group. Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders. Leukemia Res 2005;29:481\u201391.","journal-title":"Leukemia Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0407-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-007-0407-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0407-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0407-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T06:36:12Z","timestamp":1652596572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-007-0407-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,30]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s00259-007-0407-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,30]]},"assertion":[{"value":"30 March 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}